Tommy’s news, 2017
The Manchester Antenatal Vascular Clinic (MAViS) at Saint Mary’s Hospital celebrated its 5th birthday in June, with families who have gone on to have successful pregnancies following specialised care at the clinic.
In the five years since it was set up, MAViS and the team have helped women who have a high risk of hypertension in pregnancy, by providing additional monitoring, scans & support thanks to funding from the National Institute for Health Research (NIHR) and Tommy's.
The celebration was a chance to catch up with families who had attended the clinic, highlight the outcomes and impact of the clinic’s research and look ahead to future clinical studies.
The MAViS clinic is run by Consultant Obstetrician, Dr Jenny Myers, and a team of specialised midwives who lead the way in antenatal vascular care. The team has grown a portfolio of clinical research since it launched five years ago, including the Beetroot in Pregnancy Trial for the treatment of chronic hypertension.
This study was the first to test the blood pressure lowering effects of beetroot juice as a dietary supplement in pregnancy. The team have also just launched their CHERRY Trial which will investigate the effects of an amino acid supplement L-Citrulline for the treatment of high blood pressure and prevention of pregnancy complications. Other studies at the clinic have evaluated a new test - placental growth factor (PGF) to determine how it effects clinical care for women with placental disease.
Dr Myers said,
“The MAViS clinic team have cared for in excess of 600 women who require additional monitoring throughout their pregnancies. The clinic is able to ensure their blood pressure medication is optimised and that their care is tailored to their individual requirements. I would like to thank all the families who came out to celebrate our study achievements and gave us the opportunity to meet their special new arrivals.”
Karen and her one year old son Oliver were one of the families who came out to celebrate with the team. Previous to having Oliver, Karen sadly lost a baby two weeks after she was born. She had started to lose hope when a subsequent pregnancy was high risk. It was then that Karen was referred to the clinic for specialist treatment and only had high praise for the team. Karen said,
“I wouldn’t have a baby if it wasn’t for the MAViS clinic”
From the bottom of our hearts, and on behalf of the families this centre is helping, thank you!
Today, we are thrilled to announce that we are opening the UK's first national centre dedicated to miscarriage research!
Leading clinicians at the Tommy's National Centre for Miscarriage Research
1 in 4 women experience a miscarriage in their lifetime. This is a quarter of all mothers-to-be, a quarter of all families affected by loss. Tommy’s believes that the current situation can and must change – so in 2016, we opened the UK’s first national centre dedicated to miscarriage research.
Miscarriage is by far the biggest cause of pregnancy loss in the UK, and it’s also the least understood. Tommy's has opened the UK's first national research centre dedicated to early miscarriage.
1 in 4 pregnancies end in miscarriage.1 in 100 women have 3 or more miscarriages in a row. Research into this area of pregnancy loss has been underfunded for years.
Miscarriage is misunderstood and current policy is unacceptable. We want to change that